Leap Therapeutics Inc (LPTX)
3.24
0.00 (0.00%)
USD |
NASDAQ |
May 07, 11:28
Leap Therapeutics Free Cash Flow: -43.75M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -43.75M |
| September 30, 2023 | -46.39M |
| June 30, 2023 | -48.15M |
| March 31, 2023 | -50.23M |
| December 31, 2022 | -49.04M |
| September 30, 2022 | -46.75M |
| June 30, 2022 | -42.60M |
| March 31, 2022 | -38.09M |
| December 31, 2021 | -35.16M |
| September 30, 2021 | -30.43M |
| June 30, 2021 | -28.92M |
| March 31, 2021 | -30.62M |
| December 31, 2020 | -25.96M |
| September 30, 2020 | -25.86M |
| June 30, 2020 | -26.23M |
| March 31, 2020 | -23.96M |
| December 31, 2019 | -27.00M |
| September 30, 2019 | -28.16M |
| June 30, 2019 | -28.65M |
| March 31, 2019 | -27.42M |
| December 31, 2018 | -26.03M |
| Date | Value |
|---|---|
| September 30, 2018 | -25.35M |
| June 30, 2018 | -20.26M |
| March 31, 2018 | -21.26M |
| December 31, 2017 | -22.20M |
| September 30, 2017 | -23.14M |
| June 30, 2017 | -28.15M |
| March 31, 2017 | -27.73M |
| December 31, 2016 | -25.48M |
| September 30, 2016 | -9.369M |
| June 30, 2016 | -7.566M |
| March 31, 2016 | -6.618M |
| December 31, 2015 | -8.102M |
| September 30, 2015 | -22.56M |
| June 30, 2015 | -22.22M |
| March 31, 2015 | -20.88M |
| December 31, 2014 | -18.24M |
| September 30, 2014 | -16.44M |
| June 30, 2014 | -13.15M |
| March 31, 2014 | -11.26M |
| December 31, 2013 | -10.06M |
Free Cash Flow Range, Past 5 Years
-50.23M
Minimum
Mar 2023
-23.96M
Maximum
Mar 2020
-35.58M
Average
-30.62M
Median
Mar 2021
Free Cash Flow Benchmarks
| Cutera Inc | -170.88M |
| OrthoPediatrics Corp | -46.03M |
| AIM ImmunoTech Inc | -21.85M |
| Protalix BioTherapeutics Inc | -2.467M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.38M |
| Free Cash Flow Per Share (Quarterly) | -0.3836 |
| Free Cash Flow Yield | -66.12% |